KRAS and neoplasm: The other reported negative prognostic factors were Kras mutation [20], BRAF mutation [11], intrahepatic recurrence [10], LTP at the 6-month follow-up [17], high tumor grade [11], distant metastasis at diagnosis of the primary tumor [11], and previous radiation therapy [11].